The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Local drug delivery strategies for cancer treatment: Gels, nanoparticles, polymeric films, rods, and wafers
Open accessAbstract
Polymer-based drug delivery depots have been investigated over the last several decades as a means to improve upon the lack of tumor targeting and severe systemic morbidities associated with intravenous chemotherapy treatments. These localized therapies exist in a variety of form factors designed to facilitate the delivery of drug directly to the site of disease in a controlled manner, sparing off-target tissue toxicities. Many of these depots are biodegradable and designed to maintain therapeutic concentrations of drug at the tumor site for a prolonged period of time. Thus a single implantation procedure is required, sometimes coincident with tumor excision surgery, and thereby biodegrading following complete release of the loaded active agent. Even though localized polymer depot delivery systems have been investigated, a surprisingly small subset of these technologies has demonstrated potentially curative preclinical results for cancer applications, and fewer have progressed toward commercialization. The aims of this article are to review the most well-studied and efficacious local polymer delivery systems from the last two decades, to examine the rationale for utilizing drug-eluting polymer implants in cancer patients, and to identify the patient cohorts that could most benefit from localized therapy. Finally, a discussion of the physiological barriers to localized therapy (i.e. drug penetration, transport), technical hurdles, and future outlook of the field is presented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Xu, J., & Ward, E. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20073 · Cited by 12,596
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233 · cited 1×
“Polymer-based drug delivery systems have been investigated over the last few decades as a means of achieving high therapeutic concentrations of chemotherapy to the site of malignant disease in cancer patients[1-10].”
BackgroundHigh Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Gelderblom, H., Verweij, J., Nooter, K., & Sparreboom, A. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00171-x · Cited by 1,655
Chitosan and its derivatives for tissue engineering applications
Kim, I.-Y., Seo, S.-J., Moon, H.-S., Yoo, M.-K., Park, I.-Y., Kim, B.-C., & Cho, C.-S. (2008) · Biotechnology Advances · doi:10.1016/j.biotechadv.2007.07.009 · Cited by 1,433
Novel injectable neutral solutions of chitosan form biodegradable gels in situ
Chenite, A., Chaput, C., Wang, D., Combes, C., Buschmann, M. D., Hoemann, C. D., Leroux, J. C., Atkinson, B. L., Binette, F., & Selmani, A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00116-2 · Cited by 1,406
Brem, H., Piantadosi, S., Burger, P. C., Walker, M., Selker, R., Vick, N. A., Black, K., Sisti, M., Brem, S., Mohr, G., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90755-6 · Cited by 1,389
Westphal, M., Hilt, D. C., Bortey, E., Delavault, P., Olivares, R., Warnke, P. C., Whittle, I. R., Jääskeläinen, J., & Ram, Z. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.79 · Cited by 1,330
TORCHILIN, V (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.009 · Cited by 1,273
Hypersensitivity reactions from taxol.
Weiss, R. B., Donehower, R. C., Wiernik, P. H., Ohnuma, T., Gralla, R. J., Trump, D. L., Baker, J. R., Van Echo, D. A., Von Hoff, D. D., & Leyland-Jones, B. (1990) · Journal of Clinical Oncology · doi:10.1200/jco.1990.8.7.1263 · Cited by 1,174
Cited by
Emerging Frontiers in Drug Delivery
Tibbitt, M. W., Dahlman, J. E., & Langer, R. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.5b09974 · Cited by 975
Nanomedicine in cancer therapy
Fan, D., Cao, Y., Cao, M., Wang, Y., Cao, Y., & Gong, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01536-y · Cited by 878
Recent applications of PLGA based nanostructures in drug delivery
Mir, M., Ahmed, N., & Rehman, A. U. (2017) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2017.07.038 · Cited by 621
Injectable hydrogel-based drug delivery systems for local cancer therapy
Norouzi, M., Nazari, B., & Miller, D. W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.07.006 · Cited by 558
Superhydrophobic materials for biomedical applications
Falde, E. J., Yohe, S. T., Colson, Y. L., & Grinstaff, M. W. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.050 · Cited by 468
Self-citationBacterial Cellulose-Based Composite Scaffolds for Biomedical Applications: A Review
Liu, W., Du, H., Zhang, M., Liu, K., Liu, H., Xie, H., Zhang, X., & Si, C. (2020) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.0c00125 · Cited by 447
Precise nanomedicine for intelligent therapy of cancer
Chen, H., Gu, Z., An, H., Chen, C., Chen, J., Cui, R., Chen, S., Chen, W., Chen, X., Chen, X., et al. (2018) · Science China Chemistry · doi:10.1007/s11426-018-9397-5 · Cited by 409
Bioavailability of phytochemicals and its enhancement by drug delivery systems
Aqil, F., Munagala, R., Jeyabalan, J., & Vadhanam, M. V. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.032 · Cited by 398
Stewart, S. A., Domínguez-Robles, J., Donnelly, R. F., & Larrañeta, E. (2018) · Polymers · doi:10.3390/polym10121379 · Cited by 390
Drug delivery from gelatin-based systems
Foox, M., & Zilberman, M. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1037272 · Cited by 360
Local Cancer Recurrence: The Realities, Challenges, and Opportunities for New Therapies
Mahvi, D. A., Liu, R., Grinstaff, M. W., Colson, Y. L., & Raut, C. P. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21498 · Cited by 338
Self-citationYang, G., Li, X., He, Y., Ma, J., Ni, G., & Zhou, S. (2018) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2017.12.003 · Cited by 336
A 3D-printed local drug delivery patch for pancreatic cancer growth suppression
Yi, H.-G., Choi, Y.-J., Kang, K. S., Hong, J. M., Pati, R. G., Park, M. N., Shim, I. K., Lee, C. M., Kim, S. C., & Cho, D.-W. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.015 · Cited by 260
Macroscale biomaterials strategies for local immunomodulation
Dellacherie, M. O., Seo, B. R., & Mooney, D. J. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0106-3 · Cited by 255
Cancer‐Targeting Nanoparticles for Combinatorial Nucleic Acid Delivery
Vaughan, H. J., Green, J. J., & Tzeng, S. Y. (2020) · Advanced Materials · doi:10.1002/adma.201901081 · Cited by 255
Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
Abdalla, A. M. E., Xiao, L., Ullah, M. W., Yu, M., Ouyang, C., & Yang, G. (2018) · Theranostics · doi:10.7150/thno.21674 · Cited by 240
Fathi, M., Alami-Milani, M., Geranmayeh, M. H., Barar, J., Erfan-Niya, H., & Omidi, Y. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.01.122 · Cited by 194
Engineered in-situ depot-forming hydrogels for intratumoral drug delivery
Fakhari, A., & Anand Subramony, J. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.014 · Cited by 164
Single- versus Dual-Targeted Nanoparticles with Folic Acid and Biotin for Anticancer Drug Delivery
Jurczyk, M., Jelonek, K., Musiał-Kulik, M., Beberok, A., Wrześniok, D., & Kasperczyk, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13030326 · Cited by 133
Gupta, V., & Trivedi, P. (2018) · Lipid Nanocarriers for Drug Targeting · doi:10.1016/b978-0-12-813687-4.00015-3 · Cited by 96
Injectable, self-healing chimeric catechol-Fe(III) hydrogel for localized combination cancer therapy
Yavvari, P. S., Pal, S., Kumar, S., Kar, A., Awasthi, A. K., Naaz, A., Srivastava, A., & Bajaj, A. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00741 · Cited by 85
Wu, D., Shi, X., Zhao, F., Chilengue, S. T. F., Deng, L., Dong, A., Kong, D., Wang, W., & Zhang, J. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.06.033 · Cited by 81
Ramot, Y., Rotkopf, S., Gabai, R. M., Zorde Khvalevsky, E., Muravnik, S., Marzoli, G. A., Domb, A. J., Shemi, A., & Nyska, A. (2016) · Toxicologic Pathology · doi:10.1177/0192623316645860 · Cited by 64
Wang, D., Luo, M., Huang, B., Gao, W., Jiang, Y., Li, Q., Nan, K., & Lin, S. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1748759 · Cited by 38
Clinical translation of nanomedicines for brain diseases: Current challenges and future directions
Wang, G., Wang, N., Xia, X., Ismail, M., & Shi, B. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114426 · Cited by 33
Metadata
- Authors
- Wolinsky, J. B., Colson, Y. L., & Grinstaff, M. W.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 159
- Issue
- 1
- Pages
- 14-26
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2027147390
- Cited by
- 845
- References
- 89
- FWCI
- 12.39
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.